Direct-acting antiviral agents against hepatitis C virus and lipid metabolism

doi:10.3748/wjg.v23.i31.5645

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 31

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10028)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series.

Item

Count

PDF

1024

WORD

288

HTML

4846

Figures (1-2)

289

Sum=6447

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

443

Download

759

Sum=1202

Publishing Process of This Article

Item

Count

Browse

923

Download

1456

Sum=2379

Aug 21, 2017 (publication date) through Dec 23, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastroenterol. Aug 21, 2017; 23(31): 5645-5649
Published online Aug 21, 2017. doi: 10.3748/wjg.v23.i31.5645

Full Size Figure Download Figure

Figure 1 Hepatitis C virus and fatty acid synthesis. DAAs: Direct-acting antiviral agents; HCV: Hepatitis C virus; HMG-CoA, 3-hydroxy-3-methylglutaryl coenzyme A.

Citation: Kanda T, Moriyama M. Direct-acting antiviral agents against hepatitis C virus and lipid metabolism. World J Gastroenterol 2017; 23(31): 5645-5649
URL: https://www.wjgnet.com/1007-9327/full/v23/i31/5645.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i31.5645